Patent · US Active

Compositions and methods for isolation of circulating tumor cells (CTC)

US10941452B2 · kind B2 · utility

0Cited by
5References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 5, 2015
Grant dateMar 9, 2021
Priority date
Expiry dateOct 5, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/53
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method useful for identifying and isolating live circulating tumor cells is described. The method utilizes an adenoviral vector comprising a replication-competent adenovirus in which the E1 gene region is expressed under the control of a telomerase-specific promoter and further comprises a second expression cassette containing a marker protein, optionally fused to a detectable cell surface marker to permit detection of circulating tumor cells lacking cell surface markers. The method involves combining ex vivo a test sample from a patient suspected of having circulating tumor cells, an adenoviral probe system, and culture media for the cells. The test sample is incubated with the adenoviral system for a sufficient time to permit expression of the reporter protein. The marker gene expression can thereafter be quantitated and the marker-expressing cells may optionally be collected for further analysis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.